Part D
Part D
Ensuring a Robust Medicare Drug Benefit
Schaeffer researchers study Part D’s impact on formulary and benefit design, patient costs, innovation and overall health, with a focus on ensuring Medicare beneficiaries can access the high-value medications they need.
Related Topics
Top Stories View All
News
Older Americans Are Taking More Medications, With More Than 1 in 5 at Risk for a Major Drug Interaction
Featured Experts: Dima M. Qato
In The News View All
Money
Ginsburg offers advice for Medicare beneficiaries shopping for a new plan
Featured Experts: Paul Ginsburg
Axios
A recent historic drop in drug prices is largely driven by market forces, Joyce explains
Featured Experts: Geoffrey Joyce
Morning Brew
Qato discusses how new PBM reforms may protect pharmacies and patient access
Featured Experts: Dima M. Qato
Tradeoffs
Trish interviewed on rising Medicare drug plan costs and narrowing options
Featured Experts: Erin Trish
The Hill
CMS staffing shortages could make the Medicare enrollment season challenging for beneficiaries, Blum warns
Featured Research
Reforming the Medicare Part D Benefit Design: Financial Implications for Beneficiaries, Private Plans, Drug Manufacturers, and the Federal Government
Researchers evaluate prescription drug claims from Medicare Part D beneficiaries to evaluate the current spending distribution.
Experts: Erin Trish, Geoffrey Joyce
